Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Scientists at Vertex Pharmaceuticals patent new protein kinase inhibitors

Nov. 9, 2012

Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor

Nov. 9, 2012

Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors

Nov. 9, 2012

IMA-901 receives FDA orphan designation, phase III study completes enrollment

Nov. 9, 2012

T-3256336 proven to be a highly effective inhibitor of tumor growth in vivo

Nov. 9, 2012

FDA grants fast track status for etirinotecan pegol in metastatic breast cancer

Nov. 9, 2012

Senesco Technologies expands study of SNS01-T

Nov. 9, 2012

Kancera reports preclinical data for pancreatic cancer compounds

Nov. 9, 2012

Aileron Therapeutics develops new oncology drug candidate

Nov. 8, 2012

Bristol-Myers Squibb patents new lysophospholipid receptor antagonists

Nov. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....